ArborMetrix - Comprehensive Analysis Report

Summary

ArborMetrix is a privately held company, founded in 2011 and headquartered in Ann Arbor, Michigan, operating within the Enterprise Systems (Healthcare) industry. The company specializes in healthcare analytics, with a core business centered on advancing healthcare through data science. ArborMetrix transforms complex real-world data into actionable insights, facilitating informed decision-making across the healthcare ecosystem. Its platform currently serves over 15,000 healthcare providers, managing more than 39 million patient records and 1.5 million registry users.

The mission of ArborMetrix is to advance healthcare through data science by delivering high-impact, intuitive technology and analytics. The company's vision is to be a recognized leader in healthcare data analytics, enabling organizations to optimize clinical and financial performance, improve patient outcomes, and drive real-time interventions through predictive analytics. ArborMetrix aims to empower all stakeholders with a central source of data to uncover the drivers of outcomes and variation, thereby enhancing patient care and operational efficiency.

1. Strategic Focus & Objectives

Core Objectives

ArborMetrix's strategic focus is on providing clinical performance analytics tools that leverage data science to improve healthcare outcomes. The company's main business objectives include:

Optimizing clinical and financial performance for healthcare organizations.

Improving patient outcomes through data-driven insights.

Facilitating better clinical decisions with timely data presentation.

Driving real-time interventions through predictive analytics.

Empowering healthcare teams with meaningful and actionable information.

Specialization Areas

ArborMetrix specializes in creating quality improvement frameworks that are adaptable to the specific requirements and pressures within the health ecosystem. A key area of expertise is in patient registries, which are utilized to:

Measure and address health equity initiatives.

Conduct robust research.

Facilitate clinical trials, including post-market surveillance.

The company's solutions scrutinize, evaluate, and determine next steps for quality initiatives, emphasizing accountability, compliance, effectiveness, efficiency, performance, reimbursements, and patient outcomes.

Target Markets

ArborMetrix targets a broad spectrum of healthcare stakeholders, including:

Medical societies and advocacy groups.

Healthcare providers.

Payers (insurance companies and other funding bodies).

Government entities.

The company's market positioning strategy focuses on providing tailored analytics solutions that cater to the diverse needs of these segments, enabling them to derive maximum value from their healthcare data.

2. Financial Overview

Funding History

ArborMetrix is a privately held company that has successfully raised a total of $34.7 million in funding. Other reported figures for total funding include $32.4 million and $31.5 million. The company is identified as a Series C company, indicating a mature stage of venture capital financing. Key investors include Samuel Zell & Robert H Lurie, North Coast Technology Investors, and Huron River Ventures. These funds have been instrumental in supporting the company's growth, technological advancements, and market expansion.

ArborMetrix generates an estimated annual revenue of $6 million, with some reports indicating $6.9 million.

3. Product Pipeline

ArborMetrix does not engage in traditional pharmaceutical or biotechnology pipeline development for drug trials. Instead, its "pipeline development" is centered on enhancing and advancing clinical data registries and their capabilities. The company supports registry-based studies and clinical trials through various mechanisms:

Patient Identification and Enrollment: Assisting in identifying patients suitable for enrollment in studies.

Data Collection: Facilitating the collection of data through custom patient surveys and electronic case report forms.

Data Mapping: Providing crucial data mapping services to standardize and integrate diverse data sources.

The core of ArborMetrix's approach is generating Real-World Evidence (RWE) from these registries to understand treatment effectiveness, impact, and adoption. This encompasses:

Post-Market Surveillance: Monitoring medical devices and pharmaceuticals after they have been released to the market.

Patient Cohort Definition: Defining specific patient groups for research purposes.

Patient-Reported Outcomes (PROs): Holistically incorporating PROs to provide a comprehensive view of patient experiences and health status.

ArborMetrix aims to transform raw data into valuable tools for trial sponsors through sophisticated patient cohort analytics, enabling the precise identification and comparison of different patient groups for research and clinical insights.

4. Technology & Innovation

Technology Stack

ArborMetrix offers a flexible technology software platform, primarily featuring AMxCore. This platform is engineered for high-quality data ingestion, enrichment, and transformation, designed to reveal practical insights and generate real-world evidence. AMxCore is a foundational component that supports the development of customized clinical data registries, providing a robust infrastructure for complex healthcare analytics.

Proprietary Developments

The company's technological capabilities and scientific methodologies are extensive and include:

Predictive Analytics and Outcomes Calculators: Leveraging data science to model and forecast outcomes and risks at the point of care. This empowers clinicians to make informed treatment decisions and proactively avoid complications. An example is the Michigan Bariatric Surgery Collaborative (MBSC) Predictive Outcomes Calculator, which forecasts weight loss, comorbidity resolution, and complication rates after bariatric surgery.

Risk and Reliability Adjustment: The platform integrates advanced proprietary risk and reliability adjustments to ensure rigorous data analysis and deliver highly actionable insights.

Data Integration: ArborMetrix employs proven technologies for seamless integration of data from various sources, including Case Report Forms (CRFs), Patient-Reported Outcomes (PROs), and Electronic Health Record (EHR) systems. The platform processes large volumes of diverse data, securely aggregating and transforming it to support research.

AMxMIPS: A dedicated module for streamlined MIPS (Merit-based Incentive Payment System) reporting, allowing healthcare providers to report across all categories via Qualified Clinical Data Registry (QCDR) or QR.

AMxIntelligence: This module provides data-driven clinical decision support by combining clinical data and patient-reported outcomes with predictive analytics to forecast the outcomes, risks, and results of various procedures and therapies.

AMxEngage: An interactive patient engagement module designed to collect patient-reported outcomes through surveys and dashboards, offering a more complete and nuanced view of quality from the patient's perspective.

Real-World Evidence (RWE) Engine: AMxCore utilizes advanced statistical models to ensure fair comparisons and generate research-grade evidence from real-world data.

While specific patent details are not publicly emphasized, ArborMetrix highlights its "advanced proprietary risk and reliability adjustments" and "industry-changing econometric research," underscoring the innovative and distinctive nature of its analytical technology and informatics solutions that simplify the complexities of gleaning real-world evidence.

5. Leadership & Management

ArborMetrix's leadership team is composed of experts who bring together deep knowledge from the intersection of healthcare, business, and technology.

Executive Team

Maria Siambekos: Chief Executive Officer. Appointed CEO in May 2021, Maria Siambekos possesses decades of executive leadership experience in healthcare technology, including roles at Vynca, Healthbox, GE Healthcare, and TheraDoc. She began her career as a clinical scientist at The University of Chicago and holds a B.S. in